tiprankstipranks
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH
US Market
AUPH
Aurinia Pharmaceuticals
RESEARCH TOOLSreports
Want to see AUPH full AI Analyst Report?

Aurinia Pharmaceuticals (AUPH) Income Statement

2,120 Followers

Aurinia Pharmaceuticals Income Statement

Last quarter (Q4 2025), Aurinia Pharmaceuticals's total revenue was $77.11M, an increase of 28.81% from the same quarter last year. In Q4, Aurinia Pharmaceuticals's net income was $210.79M. See Aurinia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 283.06M$ 235.13M$ 175.51M$ 134.03M$ 45.60M
Gross Profit
$ 250.39M$ 206.88M$ 161.37M$ 128.37M$ 44.51M
Operating Expenses
$ 145.48M$ 211.57M$ 253.06M$ 239.84M$ 225.25M
Depreciation and Amortization
$ 9.27M$ 19.45M$ 11.65M$ 2.71M$ 2.76M
EBITDA
$ 127.76M$ 31.73M$ -63.05M$ -103.65M$ -177.44M
Operating Income
$ 104.91M$ -4.69M$ -91.69M$ -111.47M$ -180.74M
Other Income/Expenses
$ 9.24M$ 12.13M$ 14.22M$ 5.12M$ 529.00K
Pretax Income
$ 114.16M$ 7.45M$ -77.47M$ -106.35M$ -180.21M
Net Income
$ 287.20M$ 5.75M$ -78.02M$ -108.18M$ -180.97M
Per Share Metrics
Basic EPS
$ 2.14$ 0.04$ -0.54$ -0.76$ -1.40
Diluted EPS
$ 2.07$ 0.04$ -0.54$ -0.76$ -1.40
Weighted Average Shares Outstanding
 134.37M 143.06M 143.24M 141.91M 129.37M
Weighted Average Shares Outstanding (Diluted)
 138.70M 146.19M 143.24M 141.91M 129.37M
Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History